Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee advances bill to expand insurance access to continuous glucose monitors
Summary
The Senate Business, Labor and Economic Affairs Committee voted to concur on House Bill 947, which would require insurers to cover continuous glucose monitors when a clinician deems them medically necessary instead of waiting until a patient is on insulin; supporters said the devices improve care and can reduce long-term costs.
Representative Fiona Nave, the House sponsor, told the Senate Business, Labor and Economic Affairs Committee that House Bill 947 would require insurers to approve continuous glucose monitors (CGMs) when a treating clinician determines they are medically necessary, rather than linking coverage to Medicare-style insulin thresholds. "A continuous glucose monitoring device is an alternative to finger sticks to help manage type 1 or type 2 diabetes," Nave said, describing CGMs as the "gold standard" for diabetes care.
Supporters said the devices provide continuous data that…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat